Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Automated MRI pipeline standardises preclinical stroke damage measurement
2+ day, 1+ hour ago (760+ words) Researchers at the Keck School of Medicine of USC have developed an open-source, AI-assisted MRI analysis pipeline capable of processing thousands of preclinical stroke scans with expert-level accuracy, addressing a critical reproducibility challenge in the translation of experimental stroke therapies…...
Scientists identify a new vaccine design strategy for stronger HIV immunity
2+ day, 3+ hour ago (962+ words) Researchers have shown in mice that vaccine nanoparticles with greater avidity produce stronger, longer-lasting immune responses and give rare broadly neutralising antibody precursor B cells a competitive advantage in germinal centres, adding a new engineering variable to HIV vaccine design....
Fibroblast barrier linked to immunotherapy resistance in colorectal cancer
3+ day, 3+ hour ago (984+ words) Why do some colorectal cancers resist immunotherapy? Analysis of patient tumour samples has identified a population of fibroblasts that could help explain treatment resistance. Immune checkpoint blockade works by removing inhibitory signals that limit T-cell activity, allowing immune cells to…...
Meis2 gene identified as potential therapeutic target for neurodevelopmental disorders
3+ day, 1+ hour ago (378+ words) A Mass General Brigham-led study has identified Meis2 as a candidate gene capable of restoring impaired neuronal plasticity and reducing seizures in a preclinical model of neurodevelopmental disorders. Researchers at Mass General Brigham have identified a gene that may help restore…...
Nanomedicine for glioblastoma: overcoming the blood-brain barrier
3+ day, 2+ hour ago (597+ words) A comprehensive new review assesses the emerging landscape of nanoparticle-based delivery systems and maps the translational challenges that must be resolved before nanomedicine can become a routine component of clinical care. Glioblastoma is currently one of the hardest cancers to…...
Tissue chips for cancer immunotherapy safety testing enter FDA ISTAND pilot programme
3+ day, 22+ hour ago (682+ words) A modular tissue-chip platform incorporating ultrathin human cell membranes and real-time sensors has been accepted into the FDA’s ISTAND pilot programme, marking a significant regulatory step towards qualifying the technology as a drug discovery tool capable of predicting immunotherapy-associated toxicities…...
How CAR T cells are being engineered to target tumour's 'soft spot"
4+ day, 1+ hour ago (532+ words) Researchers have engineered a genetic system capable of detecting the mechanical softness of tumour cells and reprogramming that physical state into a synthetic antigen target, offering a new conceptual framework for tackling treatment-resistant cancer stem-like cell populations in solid tumours....
Reducing drug development failures with human-relevant models and AI
5+ day, 5+ hour ago (852+ words) Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access to technologies that were unimaginable mere decades…...
AI identifies experimental drug targeting undruggable cancer protein
5+ day, 3+ hour ago (367+ words) A preclinical study published ha demonstrated how AI-assisted screening can unlock challenging cancer targets, with Mayo Clinic researchers identifying a GIPC1 inhibitor that slows tumour growth and potentiates gemcitabine activity in pancreatic cancer models. Researchers at Mayo Clinic have used artificial…...
Insilico Medicine nominates AI-designed candidate for ocular diseases
5+ day, 23+ hour ago (436+ words) Insilico Medicine has nominated an artificial intelligence-designed drug candidate for the potential treatment of several inflammatory and degenerative eye diseases including dry age-related macular degeneration (dry AMD), uveitis and dry eye disease. The company said ISM9077 had been selected as a…...